Elder Pharmaceuticals reports 15% fall in Q4 net profit

17 May 2012 Evaluate

Elder Pharmaceuticals has posted 15.46% fall in its consolidated net profit at Rs 14.60 crore for the quarter ended March 31, 2012 as compared to Rs 17.27 crore in the corresponding period of previous fiscal. The fall is mainly on account of reduction in material costs.

However, the company’s consolidated total income stood at Rs 346.90 crore for the quarter under review, up by 13.30% as against Rs 306.17 crore for the same period of previous fiscal.

Elder Pharmaceuticals (EPL) has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×